Word

ORCHESTRATING THE IMMUNE SYSTEM

Status

Pending

Status Code

730

Status Date

Tuesday, March 5, 2024

Serial Number

97518230

Mark Type

4000

Filing Date

Monday, July 25, 2022

Published for Opposition

Tuesday, September 5, 2023

Trademark Owner History

Mozart Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders

Trademark Events

Mar 6, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 5, 2024

Sou Extension 1 Granted

Mar 5, 2024

Sou Extension 1 Filed

Mar 5, 2024

Sou Teas Extension Received

Oct 31, 2023

Noa E-Mailed - Sou Required From Applicant

Sep 5, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2023

Published For Opposition

Aug 16, 2023

Notification Of Notice Of Publication E-Mailed

Aug 3, 2023

Approved For Pub - Principal Register

Jul 10, 2023

Teas/Email Correspondence Entered

Jul 10, 2023

Correspondence Received In Law Office

Jul 10, 2023

Teas Response To Office Action Received

Jun 1, 2023

Notification Of Non-Final Action E-Mailed

Jun 1, 2023

Non-Final Action E-Mailed

Jun 1, 2023

Non-Final Action Written

May 10, 2023

Assigned To Examiner

Jul 28, 2022

New Application Office Supplied Data Entered

Jul 28, 2022

New Application Entered